Drug delivery into the brain using implantable polymeric systems;Liberation de principes actifs dans le cerveau a partir de systemes polymeres implantables

S.T.P. Pharma Sciences

Volumn 7, Issue 1, 1997, Pages 53-61

  Menei, P ^a   Venier Julienne, M C ^b   Benoit, J P ^b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ D'ANGERS   (France)

Author keywords

Anticancer drugs; Biodegradable polymer; Chemotherapy; Drug delivery; Microspheres; Neurooncology; Neurotrophic factors; Transmitters

Indexed keywords

ANTIMITOTIC AGENT; BETHANECHOL; BRAIN DERIVED NEUROTROPHIC FACTOR; CARMUSTINE; CORTISONE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DIMETICONE; DOPAMINE; DOXORUBICIN; ETHYLENE VINYL ACETATE COPOLYMER; FLUOROURACIL; HEPARIN; INTERFERON; LEVODOPA; METHOTREXATE; MICROSPHERE; MINOCYCLINE; MITOMYCIN; MONOSIALOGANGLIOSIDE; NERVE GROWTH FACTOR; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; NIMUSTINE; NORADRENALIN; PACLITAXEL; POLY(METHYL METHACRYLATE); POLYANHYDRIDE; POLYGLACTIN; POLYMER;

BIODEGRADATION; CONTROLLED DRUG RELEASE; DEGENERATIVE DISEASE; DRUG DELIVERY SYSTEM; DRUG TARGETING; GLIOMA; IMPLANT; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; REVIEW;

EID: 0031544326     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. TAMARGO R.J. and BREM H. - Drug delivery to the central nervous system : a review. - Neurosurgery Quarterly, 2, 259-279, 1992.
2. NEUWELT E.A., FRENKEL F.P., DIEHL J., VU L.H., RAPOPORT S. and HILL S. - Reversible osmotic blood-brain barrier disruption in humans : implications for the chemotherapy of malignant brain tumors. - Neurosurgery, 7, 44-52, 1980.
3. HARBAUGH R.E., SAUNDERS R.L. and REEDER R.F. - Use of implantable pumps for central nervous system drug infusions to treat neurological disease. - Neurosurgery, 23, 693-698, 1988.
4. HOLLISTER L.E. - Site-specific drug delivery to central nervous system : old and new. - Neurobiol. Aging, 10, 631-628, 1989.
5. PENN R.D., YORK M.M. and PAICE J.A. - Catheter systems for intrathecal drug delivery. - J. Neurosurg., 83, 215-217, 1995.
6. KREUTER J., ALYAUTDIN R.N., KHARKEVICH D.A. and IVANOV A.A. - Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). - Brain Res., 674, 171-174, 1995.
7. BICKEL U., YOSHIKAWA T. and PARDRIDGE W.M. - Delivery of peptides and proteins through the blood-brain barrier. - Adv. Drug Deliv. Rev., 10, 205-245, 1993.
8. LINDVALL O. and BJÖRKLUND A. - Transplantation strategies in the treatment of Parkinson's disease : experimental basis and clinical trials. Acta Neurol. Scand. 126, 197-210, 1989.
9. BLAU H.M. and SPINGER M.L. - Gene therapy - A novel form of drug delivery. New Engl. J. Med., 333, 18, 1995.
10. GAGE F.H., WOLFF J.A., ROSENBERG M.B., XU L., YEE J.K., SHULTS C. and FRIEDMANN T. - Grafting genetically modified cells to the brain : possibilities for the future. - Neuroscience, 23, 795-807, 1987.
11. FOLKMAN J. and LONG D.M. - The use of silicone rubber as a carrier for prolonged drug therapy. - J. Surg. Res., 4, 139-142, 1964.
12. MAYBERG M., LANGER R., ZERVAS N. and MOSKOWITZ M. - Perivascular meningeal projections from cat trigeminal ganglia : possible pathway for vascular headaches in man. -Science, 213, 228-230, 1981.
13. LANGER R. - Polymer implants for drug delivery in the brain. -J. Control. Rel., 16, 53-60, 1991.
14. MENEI P., BENOIT J.P., BOISDRON-CELLE M., FOURNIER D., MERCIER P. and GUY G. - Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres. - Neurosurgery, 34, 1058-1064, 1994.
15. DONBROW M. - Microcapsules and Nanoparticles in Medicine and Pharmacy. - CRC Press Inc., Boca Raton, Ann Arbor, London, 1992.
16. BENOIT J.P., MARCHAIS H., ROLLAND H. and VANDE VELDE V. - Biodegradable microspheres : advances in production technology. - In : Microencapsulation. Methods and Industrial Applications, S. Benita Ed., Marcel Dekker Inc., New York, 1996, pp. 35-72.
17. ODA Y., UCHIDA Y., MURATA T., MORI K., TOKURIKI Y., HANDA H., KOBAYASHI A., HASHI K. and KIELER J. -Treatment of brain tumours with anticancer pellet. Experimental and clinical study. - No Shinkei Geka, 10, 375-381, 1982.
18. RAMA B., MANDEL T., JANSEN J., DINGELDEIN E. and MENNEL H.D. - The intraneoplasic chemotherapy in a rat brain tumour model utilizing methotrexate-polymethylmethacrylate-pellets. - Acta Neurochir. Wien, 87, 70-75, 1987.
19. MENEI P., CROUE A., DANIEL V., POUPLARD-BARTHELAIX A. and BENOIT J.P. - Fate and biocompatibility of three types of microspheres implanted into the brain. - J. Biomed. Mater. Res., 28, 1079-1085, 1994.
20. MAYSINGER D., JALSENJAK V., STOLNIK S., GAROFALO L., CUELLO A.C. and JALSENJAK I. - Microencapsulated monosialoganglioside GM1 : physical properties and in vivo effects. - J. Microencapsulation, 6, 35-42, 1989.
21. MAYSINGER D., GAROFALO L., JALSENJAK I. and CUELLO A.C. - Effects of microencapsulated monosialoganglioside GM1 on cholinergic neurons. - Brain Res., 496, 165-172, 1989.
22. MITTAL S., COHEN A. and MAYSINGER D. - In vivo effects of brain derived neurotrophic factor released from microspheres. -NeuroReport, 5, 2577-2582, 1994.
23. FUJIOKA K., TAKADA Y., SATO S. and MIYATA T. - Novel delivery system for proteins using collagen as a carrier material : the minipellet. - J. Control. Rel., 33, 307-315, 1995.
24. PITT C.G., GRATZL M.M., KIMMEL G.L., SURLES J. and SCHINDLER A. - Aliphatic polyesters. II. The degradation of poly(DL-lactide), poly(ε-caprolactone), and their copolymers in vivo. - Biomaterials, 2, 215-220, 1981.
25. SPENLEHAUER G., VERT M., BENOIT J.P. and BODDAERT A. - In vitro and in vivo degradation of poly(D,L lactide/glycolide) type microspheres made by solvent evaporation method. -Biomaterials, 10, 557-563, 1989.
26. MAUDUIT J. and VERT M. - Les polymères à base d'acides lactiques et glycolique et la délivrance contrôlée des principes actifs. - STP Pharma Sci., 3, 197-212, 1993.
27. FRAZZA E.J. and SCHMIDT E.E. - A new absorbable suture. -J. Biomed. Mater. Res., 5, 43-58, 1971.
28. VISSCHER G.E., ROBINSON R.L., MAULDING H.V., FONG J.W., PEARSON J.E. and ARGENTIERI G.J. - Biodegradation of and tissue reaction to 50:50 poly (DL-lactide-co-glycolide) microcapsules. - J. Biomed. Mater. Res., 19, 349-365, 1985.
29. MONTINI M., PEDRONCELLI A., TENGATTINI F., PAGANI M. D., GIANOLA D., CORTESI L., PAGANI G. and LANCRANJAN I. - Medical applications of intramuscularly administered bromocriptine microspheres. - In : Pharmaceutical Particulate Carriers, Therapeutic Applications, A. Rolland Ed., Marcel Dekker Inc., New York, 1993, pp. 227-274.
30. RUIZ J.M. and BENOIT J.P. - In vivo peptide release from poly(d,l-lactic acid-co-glycolic acid) copolymer 50/50 microspheres. - J. Control. Rel., 16, 177-186, 1991.
31. MENEI P., DANIEL V., MONTERO-MENEI C., BROUILLARD M., POUPLARD-BARTHELAIX A. and BENOIT J.P. -Biodegradation and brain tissue reaction to poly(D-L lactide-co-glycolide) microspheres. - Biomaterials, 14, 470-478, 1993.
32. CHASIN M., LEWIS D. and LANGER R. - Polyanhydrides for controlled drug delivery. - Biopharm. Manufacturing, 1, 33-46, 1988.
33. LEONG K.W., BROTT B.C. and LANGER R. - Bioerodible polyanhydrides as drug-carrier matrices. I. Characterization, degradation, and release characteristics. - J. Biomed. Mater. Res., 19, 941-955, 1985.
34. LEONG K.W., D'AMORE P., MARLETTA M. and LANGER R. -Bioerodible polyanhydrides as drug carrier matrices. II : Biocompatibility and chemical reactivity. - J. Biomed. Mater. Res., 20, 51-64, 1986.
35. BREM H., KADER A., EPSTEIN J.I., TAMARGO R.J., DOMB A., LANGER R. and LEONG K.W. - Biocompatibility of a biodegradable controlled release polymer in the rabbit brain. -Sel. Cancer Ther., 5, 55-65, 1989.
36. ROSEN H.B., CHANG J., WNEK G.E., LINHARDT R.J. and LANGER R. - Bioerodible polyanhydrides for controlled drug delivery. - Biomaterials, 4, 131-133, 1983.
37. TAMARGO R.J., EPSTEIN J.I., REINHARD C.S., CHASIN M. and BREM H. - Brain biocompatibility of a biodegradable controlled release polymer in rats. - J. Biomed. Mater. Res., 23, 253-266, 1989.
38. BREM H., PIANTADOSI S., BURGER P.C., WALKER M., SELKER R., VICK N.A., BLACK K., SISTI M., BREM S., MOHR G., MULLER P., MORAWETZ R. and SCHOLD S.C. - Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. - Lancet, 345, 1008-1012, 1995.
39. KORNBLITH P.L. and WALKER M. - Review : Chemotherapy for malignant gliomas. - J. Neurosurg., 68, 1-17, 1988.
40. HOCHBERG F.H. and PRUITT A. - Assumptions in the radiotherapy of glioblastoma. - Neurology, 30, 907-911, 1980.
41. LAWRENCE TS. and MAYBAUM J. - Fluoropyrimidines as radiation sensitizers. - Semin. Rad. Oncol., 3, 20-28, 1993.
42. KUBO O., HIMURO H., INOUE N., TAJIKA Y., TAJIKA T., TOHYAMA T., SAKAIRI M., YOSHIDA M., KAETSU I. and KITAMURA K. - Treatment of malignant brain tumours with slowly releasing anticancer drug-polymer composites. - No Shinkei Geka, 14, 1189-1195, 1986.
43. KUBO O., TAJIKA Y., MURAGAKI Y., HIYAMA H., TAKAKURA K., YOSHIDA M. and KUMAKURA M. - Local chemotherapy with slowly-releasing anticancer drug-polymers for malignant brain tumours. - J. Control. Rel., 32, 1-8, 1994.
44. BOISDRON-CELLE M., MENEI P. and BENOIT J.P. -Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers. - J. Pharm. Pharmacol., 47, 108-114, 1995.
45. BOISDRON-CELLE M. - Préparation de microparticules de 5-fluorouracil implantables par stéréotaxie et évaluation thérapeutique chez le rat porteur d'un gliome malin. - Ph.D. Thesis, University of Paris-Sud, 1994.
46. MENEI P., BOISDRON-CELLE M., CROUE A., GUY G. and BENOIT J.P. - Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats. - Neurosurgery, 39, 117-124, 1996.
47. MENEI P. - Vectorisation dans le système nerveux central par implantation stéréotaxique de microsphères. Application à la chimiothérapie interstitielle des gliomes malins par des microsphères de BCNU ou 5-fluorouracil. - Ph.D. Thesis, University of Angers, 1995.
48. TORRES A.I., BOISDRON-CELLE M. and BENOIT J.P. -Formulation of BCNU-loaded microspheres : influence of drug stability and solubility on the design of the microencapsulation procedure. - J. Microencapsulation, 13, 41-51, 1996.
49. PAINBENI T., MENEI P., VENIER M.C., BOISDRON-CELLE M. and BENOIT J.P. - Characterization and toxicity of biodegradable BCNU-loaded microspheres : efficacy on C6 rat malignant glioma after intraperitoneal and stereotactic implantation. - 13th Pharmaceutical Technology Conference, Strasbourg, 12-14 April 1994, Vol. 1, pp. 65-74 .
50. BREM H., WALTER K.A. and LANGER R. - Polymers as controlled drug delivery devices for the treatment of malignant brain tumours. - Eur. J. Pharm. Biopharm., 39, 2-7, 1993.
51. TAMARGO R.J., MYSEROS J.S., EPSTEIN J.I., YANG M.B., CHASIN M. and BREM H. - Interstitial chemotherapy of the 9L gliosarcoma : controlled release polymers for drug delivery in the brain. - Cancer Res., 53, 329-333, 1993.
52. YANG M.B., TAMARGO R.J. and BREM H. - Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer. - Cancer Res., 49, 5103-5107, 1989.
53. BREM H., TAMARGO R.J., OLIVI A., PINN M., WEINGART J.D., WHARAM M. and EPSTEIN J.I. - Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. - J. Neurosurg., 80, 283-290, 1994.
54. GROSSMAN S.A., RIENHARD C., COLVIN O.M., CHASIN M., BRUNDRETT R., TAMARGO R.J. and BREM H. - The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. - J. Neurosurg., 76, 640-647, 1992.
55. BREM H., MAHALEY M.S., VICK N.A., BLACK K.L., SCHOLD S.C., BURGER P.C., FRIEDMAN A.H., CIRIC I.S., ELLER T.W., COZZENS J.W. and KENEALY J.N. - Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. - J. Neurosurg., 74, 441-446, 1991.
56. BREM H., EWEND M.G., PIANTADOSI S., GREENHOOT J., BURGER P.C. and SISTI M. - The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant glioma. -J. Neuro-oncol., in press.
57. SPENLEHAUER G., VEILLARD M. and BENOIT J.P. - Formation and characterization of cisplatin loaded poly(d,l-lactide) microspheres for chemoembolization. - J. Pharm. Sci., 75, 750-755, 1986.
58. STRICKER H., REMMELE T., LUDWIG H., VON BÜREN H., WOWRA B., STURM V. and ZELLER W.J. - Polymerabbau und methotrexatfreigabe von poly-DL-laktid-implantaten. - Eur J. Pharm. Biopharm., 37, 171-174, 1991.
59. OLIVI A., GILBERT M., DUNCAN K.L., CORDEN B., LENARTZ D. and BREM H. - Direct delivery of platinum-based antineoplastics to the central nervous system : a toxicity and ultrastructural study. - Cancer Chemother. Pharmacol., 31, 449-454, 1993.
60. WALTER K.A., CAHAN M.A., GUR A., TYLER B., HILTON J., COLVIN O.M., BURGER P.C., DOMB A. and BREM H. -Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. - Cancer Res., 54, 2207-2212, 1994.
61. JUDY K.D., OLIVI A., BUAHIN K.G., DOMB A., EPSTEIN J.I., COLVIN O.M. and BREM H. - Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas. - J. Neurosurg., 82, 481-486, 1995.
62. WEINGART J.D., THOMPSON R.C., TYLER B., COLVIN O.M. and BREM H. - Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma model. - Int. J. Cancer, 62, 605-609, 1995.
63. TAMARGO R.J., BOK R.A. and BREM H. - Angiogenesis inhibition by minocycline. - Cancer Res., 51, 672-675, 1991.
64. WEINGART J.D., SIPOS E.P. and BREM H. - The role of minocycline in treatment of 9L glioma. - J. Neurosurg., 82, 635-640, 1995.
65. TAMARGO R.J., LEONG K.W. and BREM H. - Growth inhibition of the 9L glioma using polymers to release heparin and cortisone acetate. - J. Neuro-Oncol., 9, 131-138, 1990.
66. CAVALIER M., BENOIT J.P. and THIES C. - The formation and characterization of hydrocortisone-loaded poly((±)-lactide) microspheres. - J. Pnarm. Pharmacol., 38, 249-253, 1986.
67. REINHARD C.S., RADOMSKY M.L., SALTZMAN W.M., HILTON J. and BREM H. - Polymeric controlled release of dexamethasone in normal rat brain. - J. Control. Rel., 16, 331-340, 1991.
68. TAMARGO R.J., SILLS A.K., REINHARD C.S., PINN M.L., LONG D.M. and BREM H. - Interstitial delivery of dexamethasone in the brain for the reduction of peritumoral edema. - J. Neurosurg., 74, 956-961, 1991.
69. GOLUMBEK P.T., AZHARI R., JAFFEE E.M., LEVITSKY H.I., LAZENBY A., LEONG K. and PARDOLL D.M. - Controlled release, biodegradable cytokine depots. A new approach in cancer vaccine design. - Cancer Res., 53, 5841-5844, 1993.
70. HAYES R.L., KOSLOW M., HIESIGER E.M., HYMES K.B., HOCHSTER H.S., MOORE E.J., PIERZ D.M., CHEN D.K., BUDZILOVICH G.N. and RANSOHOFF J. - Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma. - Cancer, 76, 840-852, 1995.
71. PHILIPS P.C., LEMOW C., CATTERALL M., COLVIN O.M., PASTAN I. and BREM H. - Transforming growth factor α-pseudomonas exotoxin fusion protein (TGFα-PE38) treatment of subcutaneous and intracranial human medulloblastoma and glioma xenografts in athymic mice. - Cancer Res., 54, 1008-1015, 1994.
72. YAMASALKI T., KIKUCHI H., MORITAKE K., NAGAO S., IWASAKI K., PAINE J.T., KAGAWA T. and NAMBA Y. - A morphological and ultrastructural investigation of normal mouse brain tissue after intra-cerebral injection of tumour necrosis factor. - J. Neurosurg., 65, 659-663, 1992.
73. FREESE A., SABEL B.A., SALTZMAN W.M., DURING M.J. and LANGER R. - Controlled release of dopamine from a polymeric brain implant. In vitro characterization. - Exp. Neurol., 103, 234-238, 1989.
74. DURING M.J., FREESE A., SABEL B.A., SALTZMAN W.M., DEUTCH A., ROTH R.H. and LANGER R. - Controlled release of dopamine from a polymeric brain implant : in vivo characterization. - Ann. Neurol., 25, 351-356, 1989.
75. WINN S.R., WAHLBERG L., TRESCO P.A. and AEBISCHER P. - An encapsulated dopamine-releasing polymer alleviates experimental Parkinsonism in rats. - Exp. Neurol., 105, 244-250, 1989.
76. BECKER J.B., ROBINSON T.E., BARTON P., SINTOV A., SIDEN R. and LEVY R.J. - Sustained behavioral recovery from unilateral nigrostriatal damage produced by the controlled release of dopamine from a silicone polymer pellet placed into the denervated striatum. - Brain Res., 508, 60-64, 1990.
77. McRAE-DEGUEURCE A., HJORTH S., DILLON D.L., MASON D.W. and TICE T.R. - Implantable microencapsulated dopamine (DA) : a new approach for slow-release DA delivery into brain tissue. - Neurosci. Lett., 92, 303-309, 1988.
78. McRAE A., HJORTH S., MASON D.W., DILLON D.L. and TICE T.R. - Micropencapsulated dopamine (DA). Induced restitution of function in 6-OH-DA denervated rat striatum in vivo : comparison between two microsphere excipients. - J. Neural Transplant. Plast., 2, 165-173, 1991.
79. McRAE A. and DAHLSTRÖM A. - Transmitter-loaded polymeric microspheres induce regrowth of dopaminergic nerve terminals in striata of rats with 6-OH-DA induced parkinsonism. -Neurochem. Int., 25, 27-33, 1994.
80. McRAE A., LING E.A., HJORTH S., DAHLSTROM A., MASON D. and TICE T. - Catecholamine-containing biodegradable microsphere implants as a novel approach in the treatment of central nervous system neurodegenerative disease. A review of experimental studies in DA-lesioned rats. - Mol. Neurobiol., 9, 191-205, 1994.
81. MAYSINGER D., JALSENJAK V., STOLNIK S. and JALSENJAK I. - Release of L-Dopa from HSA microspheres into the rat brain : in vitro and in vivo characterization by microdialysis. - In : Microencapsulation of Drugs, T.L. Whateley Ed., Harwood Academic Publisher, Chur, 1992, pp. 269-275.
82. FILIPOVIC-GRCIC J., MAYSINGER D., ZORC B. and JALSENJAK I. - Macromolecular prodrugs. IV. Alginate-chitosan microspheres of PHEA-L-dopa adduct. - Int. J. Pharm., 116, 39-44, 1995.
83. HOWARD M.A., GROSS A., GRADY M.S., LANGER R.S., MATHIOWITZ E., WINN R. and MAYBERG M.R. - Intracerebral drug delivery in rats with lesion-induced memory deficits. - J. Neurosurg., 71, 105-112, 1989.
84. SNIDER W.D. and JOHSON E.M. - Neurotrophic molecules. -Ann. Neurol., 26, 489-506, 1989.
85. UNSICKER K., GROTHE C., WESTERMANN R. and WEWETZER K. - Cytokines in neural regeneration. - Curr. Opin. Neurobiol., 2, 671-678, 1992.
86. EIDE F.F., LOWENSTEIN D.H. and REICHARDT L.F. -Neurotrophins and their receptors. Current concepts and implications for neurologic disease. - Exp. Neurol., 121, 200-214, 1993.
87. POWELL E.M., SOBARZO M.R. and SALTZMAN W.M. -Controlled release of nerve growth factor from a polymeric implant. - Brain Res., 515, 309-311, 1990.
88. KREWSON C.E., KLARMAN M.L. and SALTZMAN W.M. -Distribution of nerve growth factor following direct delivery to the brain interstitium. - Brain Res., 680, 196-206, 1995.
89. HOFFMAN D., WAHLBERG L. and AEBISCHER P. - NGF released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a fimbria fornix lesion. -Exp. Neurol., 110, 39-44, 1990.
90. YAMAMOTO S., YOSHIMINE T., FUJITA T., KURODA R., IRIE T., FUJIOKA K. and HAYAKAWA T. - Protective effect of NGF atelocollagen mini-pellet on the hippocampal delayed neuronal death in gerbils. - Neurosci. Lett., 141, 161-165, 1992.
91. CAMARATA P.J., SURYANARAYANAN R., TURNER D.A., PARKER R.G. and EBNER T.J. - Sustained release of nerve growth factor from biodegradable polymer microspheres. -Neurosurgery, 30, 313-319, 1992.
92. MENDEZ A., CAMARATA P.J., SURYANARAYANAN R. and EBNER T.J. - Sustained intracerebral delivery of nerve growth factor with biodegradable polymer microspheres. - Methods Neurosci., 21, 150-167, 1994.
93. GHEZZO E., BENEDETTI L., ROCHIRA M., BIVIANO F. and CALLEGARO L. - Hyaluronane derivative microspheres as NGF delivery devices : preparation methods and in vitro release characterization. - Int. J. Pharm., 87, 21-29, 1992.
94. MAYSINGER D., JALSENJAK I. and CUELLO A.C. -Microencapsulated nerve growth factor : effects on the forebrain neurons following devascularizing cortical lesions. - Neurosci. Lett., 140, 71-74, 1992.
95. RIDDLE D.R., LO D.C. and KATZ L.C. - NT-4-mediated rescue of lateral geniculate neurons from effects of monocular deprivation. - Nature, 378, 189-191, 1995.
96. MAYSINGER D., FILIPOVIC-GRCIC J. and CUELLO A.C. -Effects of coencapsulated NGF and GM1 in rats with cortical lesions. - NeuroReport, 4, 971-974, 1993.
97. HEFFEZ D.S. and LEONG K.W. - Sustained release of papaverine for the treatment of cerebral vasospasm : in vitro evaluation of release kinetics and biological activity. - J. Neurosurg., 77, 783-787, 1992.
98. ESTEBE J.P., LE CORRE P., MALLEDANT Y., CHEVANNE F. and LEVERGE R. - Prolongation of spinal anaesthesia with bupivacaine-loaded (DL-lactide) microspheres. - Anesth. Analg., 81, 99-103, 1995
99. MALINOVSKY J.M., BERNARD J.M., LE CORRE P., DUMAND J.B., LEPAGE J.Y., LE VERGE R. and SOURON R. - Motor and blood pressure effects of epidural sustained-release bupivacaine from polymer microspheres : a dose response study in rabbits. -Anesth. Analg., 81, 519-524, 1995.